Meeting the burden of disease through optimising the use of pharmacists in supply chains
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Presentation
- By: BROWN, Andrew (Andrew N Brown Health System Strengthening Pty Ltd, Queanbeyan, Australia)
- Co-author(s): Andrew N Brown:,International Association of Public Health Logisticians (IAPHL),Queanbeyan,Australia|Jennifer Chen:Public Health,Boston University,Boston,United States|Ulf Janzon:Industrial Pharmacy Section (IPS) (BPP ExCo),|Wendy Walker:Military and Emergency Pharmacy Section (MEPS),|Lindsay McClure:Health and Medicines Information Section (HAMIS),|Erik Naeser:Industrial Pharmacy Section (IPS) ,|Vaiyapuri Subramaniam:Social and Administrative Pharmacy Section (SAPhS),|Rabih Hassouneh:Community Pharmacy Section (CPS),|Hammoud Luna:Community Pharmacy Section (CPS),|Patricia Kienle:Hospital Pharmacy Section (HPS),|Diogo Gouveia:European Healthcare Distribution Association (GIRP),
Medicines are a vital part of disease prevention programmes & treatment plans with the role of governments to ensure appropriate access to quality health products via sustainable, quality driven health supply chains. Pharmacists form part of this workforce used in health supply chains but in many countries where there is a shortage of pharmacists.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.